2019 American Transplant Congress

June 1-5, 2019 in Boston, MA

View by Title View Sessions

View by Date

Jump to: [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z

Results of Litmus (nct 02541916): The Liver Immune Tolerance Bio Marker Utilization Study

A. Chruscinski¹, V. Rojas-Luengas¹, S. Moshkelgosha¹, J. Luo², H. Yowanto², Z. Galvin¹, L. Lilly¹, R. Smith¹, E. Renner¹, J. Zhang¹, D. Grant¹, O. Adeyi¹, H. Atkins³, P. Juni⁴, N. Selzner¹, S. Juvet¹, G. Levy¹
Retroperitoneoscopic Native Nephrectomy in Renal Transplant Recipients with Autosomal Dominant Polycystic Kidney Disease

K. Hotta¹, D. Iwami², J. Furumido², K. Morita³, T. Tanabe⁴, T. Mochizuki⁴, H. Higuchi², N. Iwahara², T. Abe², K. Kanagawa⁴, N. Shinohara²
Retrospective Evaluation of Dapsone Prophylaxis Complications in Kidney Transplant Recipients

S. Hamel¹, V. Johnson², D. Johnson², E. Blumberg³, R. Bloom⁴, J. Trofe-Clark²
Retrospective Evaluation of Optimal Cmv Prophylaxis Regimens in Lung Transplant Patients: Analysis of Patient Outcomes Pre and Post Protocol Dosing Alterations

J. Hunt, A. Nasar, R. Walia, L. Cherrier
Retrospective Nested Case Control Study of the Impact of Immunosuppression on Post Transplant Malignancy among Adult Heart Transplant Patients

S. Crow, R. J. Bubik, S. S. Kushwaha, K. C. Mara, R. A. Dierkhising, N. L. Pereira
Return to Work after Sick Leave in Kidney Transplant Recipients: A 365-Day Cohort of the Japan Academic Consortium of Kidney Transplantation (JACK) Study

K. Miyake¹, M. Okumi¹, K. Unagami², Y. Kakuta¹, M. Furusawa¹, K. Omoto³, T. Shimizu³, M. Endo⁴, H. Ishida², K. Tanabe¹
Reverse Signaling through CD137 Ligand Promotes Tissue Repair after Ischemia-Reperfusion Kidney Injury

H. R. Cho¹, S. Lee², J. S. Lee³, S. J. Park¹, B. Kwon²
Risk Factors for 1-5 Year De Novo Cancers after Kidney Transplant (KTx) with First-Year Immunosuppression (IS) Data: An Analysis of the Choosing Immune Suppression by Efficacy and Morbidity (CISTEM) Study

V. Dharnidharka¹, D. Axelrod², Z. Zhang³, M. Schnitzler³, K. Lentine³, B. Kasiske⁴
Risk Factors for 1-5 Year Major Infection Events (MIE) after Kidney Transplant (KTx) Including First-Year Immunosuppression (IS) Data: An Analysis of the Choosing Immune Suppression in Renal Transplantation by Efficacy and Morbidity (CISTEM) Study

V. Dharnidharka¹, D. Axelrod², Z. Zhang³, M. Schnitzler³, K. Lentine³, B. Kasiske⁴
Risk Factors for Graft Loss Vary with Recipient MELD Score in Liver Transplantation

J. A. Steggerda¹, M. B. Bloom¹, T. Todo², T. V. Brennan², N. N. Nissen², A. S. Klein², I. K. Kim²

Jump to: [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z